Publications - CDPE

The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile

as part of T-DOT (Toronto Disparities, Overdose and Treatment)

The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs established to evaluate the impacts of supervised consumption services integrated within three community health agencies on health status and service use.

View publication

Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications

as part of Piloting and Evaluating Drug Checking Services in Toronto, Ontario

We report the first detection of the psychoactive veterinary compound xylazine in Toronto, the largest urban center in Canada, by the city’s drug checking service.

View publication

Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico

as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

To explore a potential relationship between overdose and injection initiation, we assessed temporal associations between experiencing a non-fatal overdose and assisting others in initiating injection drug use among persons who inject drugs in two North American cities - Vancouver, Canada and Tijuana, Mexico.

View publication

Redressing Inequities in America’s Drug Policies: An Evidence-Grounded Call for Bold Action

as part of Policy Impact Unit

In this brief for the Biden-Harris Administration, the CDPE and the Health in Justice Action Lab outline key actions to enhance the equity and effectiveness of drug policy in the United States.

View publication

What’s in Toronto’s drug supply? Results from samples checked by Toronto’s drug checking service: January 1 – December 31, 2020

as part of Piloting and Evaluating Drug Checking Services in Toronto, Ontario

Between January 1 and December 31, 2020, 1657 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.

View publication

Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings

as part of Piloting and Evaluating Drug Checking Services in Toronto, Ontario

The objective of this study was to characterise the presence of synthetic cannabinoids in the unregulated drug supply in three Canadian settings.

View publication

Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts

as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

Using mixed methods across three settings in North America, we investigated the gender composition of injection initiation events and the gendered risk environments in which they occurred.

View publication

Supervised Consumption Service Use and Recent Non-Fatal Overdose among People Who Inject Drugs in Toronto, Canada

as part of T-DOT (Toronto Disparities, Overdose and Treatment)

This study examined associations between SCS use and non-fatal overdose among PWID in Toronto, Ontario, Canada amidst the current opioid overdose epidemic, drawing on baseline data from a cohort of PWID including individuals who do and do not use SCS.

View publication

Preliminary Patterns in Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

as part of COVID-19 Rapid Assessment

The Ontario Drug Policy Research Network, the Office of the Chief Coroner for Ontario/the Ontario Forensic Pathology Service, Public Health Ontario, and the CDPE have published a report analyzing trends in opioid-related deaths and comparing circumstances of death between two groups: a COVID-19 pandemic cohort and a pre-pandemic cohort.

View publication

How Diverse is Canada’s Legal Cannabis Industry? Examining Race and Gender of its Executives and Directors

as part of Policy Impact Unit

The aim of this project was to examine the race and gender of c-suite level executives and boards of directors of licensed cannabis producers and their parent companies operating in the Canadian cannabis industry, in order to assess whether the promise of an equitable legal cannabis market has been achieved.

View publication